Business News

A ‘breadth of protection:’ Novavax’s newly-approved COVID vaccine arms the US with a new weapon against Omicron BA.5 subvariant

[ad_1]

Novavax says its vaccine prompted ‘broad immune responses’ against all COVID variants, including BA.5, in clinical data. Read More

[ad_2]

Source link

Related Articles

Back to top button